Sequential use of Ad26-based vaccine regimens in NHP to induce immunity against different disease targets.

NPJ Vaccines · 2022 · PMC9664441 · PMID 36379957

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

4a ), although it did not reach statistical significance (Supplementary Table 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.